CN1454614A - 抗癌胶囊及其制备方法 - Google Patents
抗癌胶囊及其制备方法 Download PDFInfo
- Publication number
- CN1454614A CN1454614A CN 02117062 CN02117062A CN1454614A CN 1454614 A CN1454614 A CN 1454614A CN 02117062 CN02117062 CN 02117062 CN 02117062 A CN02117062 A CN 02117062A CN 1454614 A CN1454614 A CN 1454614A
- Authority
- CN
- China
- Prior art keywords
- cancer
- grams
- radix
- carcinoma
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 11
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 10
- 208000003174 Brain Neoplasms Diseases 0.000 claims abstract description 3
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 3
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims abstract description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 3
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 3
- 201000002313 intestinal cancer Diseases 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims abstract description 3
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 claims description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 2
- 201000008275 breast carcinoma Diseases 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 claims description 2
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 claims description 2
- 208000012991 uterine carcinoma Diseases 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 208000002495 Uterine Neoplasms Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 206010046766 uterine cancer Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
抗癌胶囊及其制备方法属治疗肺癌、肝癌、脑癌、鼻咽癌、食道癌、胃癌、肠癌、乳腺癌、子宫癌的纯中药胶囊制剂。本方剂配合放化疗服用，可起增效减毒、提高免疫功能和生存质量的作用。本方剂由西洋参、三七、白花蛇舌草、半支莲、夏枯草、七叶一枝花、甘草等药味组成，经二次煎煮、浓缩滤液、提炼清膏，以及粉碎过筛、干燥颗粒，填充胶囊而成。其功能为扶正祛邪、软坚散结、益气化瘀、清热解毒，诸药谐调，共奏消瘤抗癌之功效。
Description
本发明为治疗肺癌、肝癌、脑癌、鼻咽癌、食道癌、胃癌、肠癌、乳腺癌、子宫癌、以及配合放化疗增效减毒、提高免疫功能和生存质量的纯中药胶囊制剂。其功能为扶正祛邪、软坚散结、益气化瘀、清热解毒。
本抗癌胶囊，发明人在祖传秘方“张氏化瘀散”基础上，经历20余年临床应用，在1万余例各种癌症治疗实践中，经加减化裁凝结而成。方剂由西洋参1000克、三七3000克、白花蛇舌草5000克、半支莲5000克、夏枯草5000克、七叶一枝花5000克、甘草3000克配伍组成。西洋参匡扶正气，三七活血化瘀，白花蛇舌草、半支莲、七叶一枝花等清热解毒、软坚消瘤，甘草谐调诸药，共奏消瘤抗癌功效。
本发明的制备工艺为：精选纯正白花蛇舌草、半支莲、七叶一枝花、甘草、夏枯草等中药材，加10倍量水煎煮二次，每次3小时，滤取煎液，合并后浓缩至相对密度1.30，加95度医用乙醇，使乙醇量达70％，再经过滤，滤液回收乙醇浓缩至相对密度为1.30的清膏备用；取西洋参、三七等，控制温度80±2℃干燥，粉碎，过100目筛取细粉备用；取三七、西洋参干燥细粉，加入清膏制成药粒，控制温度70±2℃干燥；将干燥颗粒用40筛筛成整粒，每粒0.5克，填充胶囊中，密封贮存，有效期二年。
本抗癌胶囊口服，每次3-4粒，一日3次，4周为一疗程。放化疗期间服法同前，无不良反应。
服药期间忌食雄鸡鲤鱼、虾、猪头、绿豆、白萝卜。
Claims (1)
- 抗癌胶囊及其制备方法，由西洋参、三七、白花蛇舌草、半支莲、夏枯草、七叶一枝花、甘草等药味组成。经二次煎煮、浓缩滤液、提炼清膏，以及粉碎过筛、干燥颗粒，填充胶囊等工艺制成。属治疗肺癌、肝癌、脑癌、鼻咽癌、食道癌、胃癌、肠癌、乳腺癌、子宫癌的纯中药胶囊制剂。其特征在于组方配伍重量比为：西洋参1000克、三七3000克、白花蛇舌草5000克、半支莲5000克、夏枯草5000克、七叶一枝花5000克、甘草3000克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021170622A CN1181857C (zh) | 2002-04-29 | 2002-04-29 | 抗癌胶囊及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021170622A CN1181857C (zh) | 2002-04-29 | 2002-04-29 | 抗癌胶囊及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1454614A true CN1454614A (zh) | 2003-11-12 |
| CN1181857C CN1181857C (zh) | 2004-12-29 |
Family
ID=29257150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021170622A Expired - Fee Related CN1181857C (zh) | 2002-04-29 | 2002-04-29 | 抗癌胶囊及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1181857C (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104352608A (zh) * | 2014-10-14 | 2015-02-18 | 武汉科德中医医院有限公司 | 一种益气活血、软坚散结、解毒止痛的中药及其制备方法 |
| CN104800467A (zh) * | 2015-05-05 | 2015-07-29 | 黄玉莲 | 直肠癌患者服用的中药方剂及制法 |
| CN105055807A (zh) * | 2015-09-25 | 2015-11-18 | 廖国荣 | 一种治疗子宫癌的中药组合物及其制备方法和应用 |
| CN105362801A (zh) * | 2014-08-28 | 2016-03-02 | 李华 | 一种治疗癌症的中药 |
| CN108743838A (zh) * | 2018-08-29 | 2018-11-06 | 欧维玖 | 癌速治疗丸的制备方法及其应用 |
| CN111999402A (zh) * | 2020-08-03 | 2020-11-27 | 长白山制药股份有限公司 | 一种筛选康艾注射液抗肿瘤药效物质基础的方法 |
-
2002
- 2002-04-29 CN CNB021170622A patent/CN1181857C/zh not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105362801A (zh) * | 2014-08-28 | 2016-03-02 | 李华 | 一种治疗癌症的中药 |
| CN104352608A (zh) * | 2014-10-14 | 2015-02-18 | 武汉科德中医医院有限公司 | 一种益气活血、软坚散结、解毒止痛的中药及其制备方法 |
| CN104800467A (zh) * | 2015-05-05 | 2015-07-29 | 黄玉莲 | 直肠癌患者服用的中药方剂及制法 |
| CN105055807A (zh) * | 2015-09-25 | 2015-11-18 | 廖国荣 | 一种治疗子宫癌的中药组合物及其制备方法和应用 |
| CN108743838A (zh) * | 2018-08-29 | 2018-11-06 | 欧维玖 | 癌速治疗丸的制备方法及其应用 |
| CN111999402A (zh) * | 2020-08-03 | 2020-11-27 | 长白山制药股份有限公司 | 一种筛选康艾注射液抗肿瘤药效物质基础的方法 |
| CN111999402B (zh) * | 2020-08-03 | 2023-11-10 | 长白山制药股份有限公司 | 一种筛选康艾注射液抗肿瘤药效物质基础的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1181857C (zh) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095736B (zh) | 一种治疗急慢性咽炎、扁桃体炎的中药组合物及其制备方法 | |
| CN1283296C (zh) | 一种咽喉保健茶及其制备方法 | |
| CN1094055C (zh) | 治疗感冒咳嗽的药物及其制备方法 | |
| CN101085219A (zh) | 治疗胃溃疡的中药方剂 | |
| CN103893722A (zh) | 一种治疗日光性皮炎的中药组合物及其制备方法 | |
| CN101537098A (zh) | 一种具有芳香通窍、清热解毒、祛湿排脓功效的药物组合及其制备方法 | |
| CN107095995B (zh) | 一种治疗胃炎和胃溃疡的药物组合物及制备方法 | |
| CN1454614A (zh) | 抗癌胶囊及其制备方法 | |
| CN111249396A (zh) | 一种治疗慢性胃炎的中药及其微粉化颗粒的制备方法 | |
| CN101045153A (zh) | 一种治疗感冒的中药 | |
| CN102940844B (zh) | 一种治疗消化不良的药物组合物 | |
| CN1408383A (zh) | 一种治疗胃肠癌的纯中药制剂及制备方法 | |
| CN101264164A (zh) | 用于肿瘤治疗的药物组合物及其制备方法 | |
| CN102085249A (zh) | 一种胃舒宁胶囊 | |
| CN101926926B (zh) | 一种治疗风湿性关节炎或类风湿性关节炎的中药制剂 | |
| CN101336976A (zh) | 一种治疗生殖器疱疹的内服中药的配方及其制备方法 | |
| WO2015149391A1 (zh) | 一种治疗慢性肠炎的中药制剂及其制备方法 | |
| CN104001041A (zh) | 一种治疗脑梗阻的中药 | |
| CN104721767A (zh) | 一种治疗小儿咳嗽的中药组合物及其制备方法 | |
| CN102940699A (zh) | 一种治疗消化不良的药物组合物 | |
| CN1060663C (zh) | 复方藏茵陈成药 | |
| CN1068217C (zh) | 一种治疗皮肤病、性病的中药 | |
| CN105381125B (zh) | 一种防治流感的中药组合物及其制备方法和应用 | |
| CN104491811A (zh) | 一种治疗风寒感冒的中药制剂 | |
| CN104208620A (zh) | 一种抗病毒制剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Dezhong Document name: Notice of conformity |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Dezhong Document name: Notification to Pay the Fees |
|
| ASS | Succession or assignment of patent right |
Owner name: WUHAN KEDE MEDICAL INVESTMENT MANAGEMENT CO., LTD. Free format text: FORMER OWNER: ZHANG DEZHONG Effective date: 20120929 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430015 WUHAN, HUBEI PROVINCE TO: 430016 WUHAN, HUBEI PROVINCE |
|
| DD01 | Delivery of document by public notice |
Addressee: Zhang Dezhong Document name: Notification of Passing Examination on Formalities |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120929 Address after: 430016 Hubei city of Wuhan province East Lake Development Zone Luoyu Road, Optics Valley world city AO Building 1 layer 010. Patentee after: Wuhan Kede medical Cci Capital Ltd Address before: 430015 Hubei city in Wuhan Province, Hankou Xinhua Road No. 166 Patentee before: Zhang Dezhong |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041229 Termination date: 20180429 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |